InvestorsObserver
×
News Home

Is Aytu Bioscience Inc (AYTU) a Winner or a Loser in the Biotechnology Industry

Wednesday, March 25, 2020 02:16 PM | InvestorsObserver Analysts

Mentioned in this article

Is Aytu Bioscience Inc (AYTU) a Winner or a Loser in the Biotechnology Industry

The 85 rating InvestorsObserver gives to Aytu Bioscience Inc (AYTU) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 99 percent of stocks in the Biotechnology industry, AYTU’s 85 overall rating means the stock scores better than 85 percent of all stocks.

Overall Score - 85
AYTU has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on AYTU!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Aytu Bioscience Inc Stock Today?

Aytu Bioscience Inc (AYTU) stock is down -16.08% while the S&P 500 has risen 3.65% as of 2:13 PM on Wednesday, Mar 25. AYTU has fallen -$0.32 from the previous closing price of $1.99 on volume of 21,555,025 shares. Over the past year the S&P 500 has fallen -10.00% while AYTU has risen 3.73%. AYTU lost -$1.88 per share the over the last 12 months.

To see the top 5 stocks in Biotechnology click here.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App